Phase II trial of oral estramustine, oral etoposide, and intravenous paclitaxel in hormone-refractory prostate cancer (Q44667340)

From Wikidata
Jump to navigation Jump to search
scientific article published in June 1999
edit
Language Label Description Also known as
English
Phase II trial of oral estramustine, oral etoposide, and intravenous paclitaxel in hormone-refractory prostate cancer
scientific article published in June 1999

    Statements

    Phase II trial of oral estramustine, oral etoposide, and intravenous paclitaxel in hormone-refractory prostate cancer (English)
    1664-1671

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit